Skip to content

Study · Animal study (in vivo) · rat · 2007

1 result

Effect of selank on cognitive processes after damage inflicted to the cerebral catecholamine system during early ontogeny.

Semenova TP, Kozlovskaya MM, Zakharova NM, Kozlovskii II, Zuikov AV

Bulletin of experimental biology and medicine1 Nov 2007Cited by 2 (Europe PMC)

PMID18683497 (opens in a new tab)DOI10.1007/s10517-007-0406-2 (opens in a new tab)PepBankPUB-18683497
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In adult Wistar rats with early-life catecholaminergic damage from 6-hydroxydopamine, Selank restored cognitive processes.

    In plain wordsIn rats with early-life damage to a brain signalling system, Selank restored thinking and learning functions.

    Peptide
    Selank
    Outcome
    IncreaseCognitive processes after catecholamine system damage
    Study

    ratn: not reported in source

    neonatal 6-hydroxydopamine catecholamine damage
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    300 microg/kgAs given in this study (rat).

    Source sentences

    Summary
    Selank (300 microg/kg) restored cognitive processes disordered by chronic artificial inhibition of the cerebral catecholaminergic system.
    1 context sentence
    Summary · context
    Effects of selank on learning, memory, and attention to sensory stimuli of different modality were studied in adult Wistar rats treated with 6-hydroxydopamine (neurotoxin selectively damaging catecholaminergic neurons and their terminals) during the first 3 days of life.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 19:08 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.